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Abstract: C-type lectin receptors and their adaptor molecules are involved in the 
recognition of glycosylated self-antigens and pathogens. However, little is known about the 
species- and organ-specific expression profiles of these molecules. We therefore 
determined the mRNA expression levels of Dectin-1, MR1, MR2, DC-SIGN, Syk, Card-9, 
Bcl-10, Malt-1, Src, Dec-205, Galectin-1, Tim-3, Trem-1, and DAP-12 in 11 solid organs 
of human and mice. Mouse organs revealed lower mRNA levels of most molecules 
compared to spleen. However, Dec-205 and Galectin-1 in thymus, Src in brain, MR2, 
Card-9, Bcl-10, Src, and Dec-205 in small intestine, MR2, Bcl-10, Src, Galectin-1 in 
kidney, and Src and Galectin-1 in muscle were at least 2-fold higher expressed compared 
to spleen. Human lung, liver and heart expressed higher mRNA levels of most genes 
compared to spleen. Dectin-1, MR1, Syk and Trem-1 mRNA were strongly up-regulated 
upon ischemia-reperfusion injury in murine kidney. Tim3, DAP-12, Card-9, DC-SIGN and 
MR2 were further up-regulated during renal fibrosis. Murine kidney showed higher DAP-12, 
Syk, Card-9 and Dectin-1 mRNA expression during the progression of lupus nephritis. 
Thus, the organ-, and species-specific expression of C-type lectin receptors is different 
between mice and humans which must be considered in the interpretation of  
related studies.  
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1. Introduction 
Multicellular organisms recognize potentially harmful dangers and rapidly trigger appropriate 
defense mechanisms that prevent or minimize tissue damage [1]. Microbial pathogen-associated 
molecular patterns (PAMPs) or endogenous danger-associated molecular patterns (DAMPs) are often 
made up of carbohydrates such as glucans, mannose or fucose [2]. C-type lectin receptors (CLR) 
recognize such glycoproteins and initiate inflammatory responses by activating different adaptor 
molecules [3]. Unlike the Toll-like receptors (TLR), CLRs are able to internalise the antigens [4]. They 
are part of a large family of proteins that contain an extracellular carbohydrate recognition domain and 
calcium-binding sites. Recent studies indicate that many CLRs, such as Dectin-1 or DC-SIGN function 
as pattern recognition receptors. Upon ligand binding CLRs activate signal transduction involving  
Syk- and Card-9-dependent activation of nuclear factor- B (NF-κB) and contribute to innate immunity 
and tissue inflammation. The current evidence on the functional roles of these molecules in host 
defense and danger control largely derives from in vitro studies or experiments using knock-out mice. 
Pattern recognition receptor genes show large homologies among species, therefore, data originating 
from mice often predict similar functions in humans [5]. However, important discrepancies exist. For 
example, humans lack functional TLR11 [6], mice lack TLR8 [7], and TLR9 is expressed in murine 
but not in human macrophages [8]. Similarly, there are also different functions of CLR in mice and 
humans. For example, murine DC-SIGN is down-regulated upon activation in dendritic cells, but 
unlike human DC-SIGN, incubation with IL-4 and IL-13 does not enhance mouse DC-SIGN 
expression [9]. Mouse DC-SIGN is not involved in T cell–DC interactions and it does not bind to 
pathogens known to interact with human DC-SIGN, such as Leishmania mexicana, cytomegalovirus, 
and HIV [9]. While the expression of the TLRs and cytosolic PRRs have been extensively 
characterized [10,11] little data are available on the species-specific expression of CLRs and their 
adaptor molecules. We hypothesized that CLRs and CLR-related molecules are differentially 
expressed in humans and mice; hence, we characterized their mRNA expression profiles in human and 
murine solid organs as well as in a number of disease models that involve innate immune responses.  
2. Results and Discussion 
2.1. C-Type Lectin Receptor mRNA Expression in Adult Human Tissues  
We used real time RT-PCR to assess the mRNA expression levels of the following innate pattern 
recognition molecules in human solid organs: Dectin-1, MR1, MR2, DC-SIGN, Syk, Card-9, Bcl-10, 
Malt-1, Src, Dec-205, Galectin-1, Tim-3, Trem-1, and DAP-12. Most of these molecules were 
constitutively expressed in human spleen (Figure 1A). DC-SIGN, Syk, and Dec-205 mRNA were only 
marginally detectable in spleen. In human thymus the mRNA levels of all aforementioned molecules 
were lower than in spleen except for DC-SIGN, Bcl-10, Dec-205 and Galectin-1. The mRNA levels of 
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some tested receptors and signaling molecules were lower or unchanged in solid organs as compared to 
spleen. However human brain revealed higher levels of Src and Galectin-1. Lung revealed only lower 
expression of Dec-205 as compared to spleen. Expression of Bcl-10, Trem-1 and Galectin-1 were more 
than 10-fold higher as compared to spleen. Liver revealed substantial higher expression levels of Bcl-10 
and Galectin-1, similar to small intestine and colon. All molecules except for Syk, Card-9, Dec-205, 
Tim-3, and DAP-12 showed higher mRNA levels in heart. Only Bcl-10 and Src were higher in kidney. 
Testis expresses substantially higher levels of MR2, Syk, Bcl-10, Malt-1, Src, and Galectin-1. MR2, 
DC-SIGN, Bcl-10, Malt-1, and Galectin-1 were found to be highly expressed in muscle. Thus, human 
organs display an organ-specific CLRs mRNA expression pattern.  
2.2. C-Type Lectin Receptor mRNA Expression in Adult Murine Tissues 
Next we determined the mRNA expression levels of the same molecules in the same 11 murine 
organs from six to eight week and six month old C57BL/6 mice. All molecules were constitutively 
expressed in mouse spleen but the mRNA level of Src was just above detection level (Figure 1B).  
In all other solid organs gene expression levels of all tested molecules were lower or similar to splenic 
expression levels. However, Dec-205 and Galectin-1 mRNA levels were higher in mouse thymus; Src 
was higher in brain, small intestine, kidney and muscle. Small intestine expressed higher levels of 
MR2, Card-9, Bcl-10, and Dec-205. In murine kidney only MR2, Bcl-10, Src, and Galectin-1 showed 
substantially higher expression.  
Figure 2 compares the organ-specific CLRs mRNA expression in humans and mice, and illustrates 
direct comparison of relative mRNA expressions between the two species. White (human) and  
black (murine) bars indicate the x-fold induction versus respective spleen mRNA expression levels. 
For example, higher mRNA levels of Bcl-10 in all organs except small intestine and brain were 
observed in humans but not in mice. Also Galectin-1 mRNA expression was higher in humans than in 
mice in all the tested organs except for kidney. Human lung showed higher expression of every tested 
molecule in comparison to murine samples. The relative Src mRNA expression in mouse brain, small 
intestine, kidney and muscle was higher than in humans. Murine kidney expressed higher levels of 
MR2 and Galectin-1 as compared to humans. MR2, Card-9 and Dec-205 mRNA expression was 
higher in murine than in human small intestine. Muscle and heart also displayed almost identical 
relative mRNA expression patterns in humans and mice. We conclude that the mRNA expression 
levels of tested molecules differ in human and mouse organs. 
2.3. C-Type Lectin Receptor mRNA Expression in Ischemia-Reperfusion Injury (IRI) 
Acute renal ischemia causes renal failure due to tubular cell necrosis as well as an activation of 
innate immunity which contributes to tissue injury and organ dysfunction [12]. We used transient renal 
pedicle clamping to study the expression of CLR throughout the course of ischemia-reperfusion  
injury (Figure 3A). Increase in mRNA expression was mostly evident for Syk, Galectin-1, Tim-3, 
Trem-1 and already at day one after renal artery clamping. Expression of Dectin-1, MR1, Syk and 
DAP-12 was higher at 10 days after injury. Card-9 and Bcl-10 were down-regulated after acute kidney 
injury. We conclude that Dectin-1, Syk, DAP-12 and MR1 mRNA are persistently induced upon renal 
ischemia-reperfusion injury which corresponds to their expression in renal mononuclear cells that 
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persistently infiltrate the postischemic kidney, especially during the late inflammatory phase and repair 
phase of renal injury. It is known that oxidative stress and ischemic injury trigger the inflammatory 
responses. Increased renal proinflammatory chemokine and cytokine expression after ischemia 
reperfusion injury (IRI), supports recruitment of immune cells to sites of inflammation. In fact 
immunostaining revealed increased numbers of CD3+ and F4/80+ immune cells in the renal interstitial 
compartment 24 h after renal artery clamping. To validate the increased mRNA level, we performed 
co-immunostaining of Syk and DAP-12 with macrophage F4/80 marker. Co-expression of F4/80 
marker with Syk or DAP-12 upon IRI was consistent with mRNA expression pattern (Figure 4). 
Figure 1. (A) C-type lectin receptors (CLR) mRNA expression in adult human tissues. 
Quantitative real-time PCR analysis was performed on pre-normalized cDNAs derived 
from poly(A)-selected DNase-treated RNAs purified from pools of healthy human tissues 
as described in methods; (B) CLR mRNA expression in adult mouse tissues. Real-time 
PCR was performed on pooled cDNAs derived from five adult six to eight week old 
C57BL/6 mice as described in methods. Biological replicates were quantified in triplicates 
and normalized to the respective GAPDH mRNA level. The results in the table are 
expressed relative to the respective expression level of each transcript in spleen. In the 
table, red shades indicate higher and green shades indicate lower mRNA levels as 
compared to the respective mRNA levels in spleen. The spleen mRNA levels are illustrated 
in the histogram on top of the table. Data in B represents means ± SEM. * indicated 
statistical significance p < 0.05. 
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Figure 1. Cont. 
 
Figure 2. CLR mRNA expression in adult human and mouse tissues. The respective 
relative human (open bars) and murine (black bars) CLRs mRNA levels from figure 1A,B 
are illustrated. The x-axis marks a ratio of 1, hence, positive values indicate stronger 
expression in humans, negative values indicate stronger expression in mice. The y-axis 
marks the fold-change in each direction. Note that the scale of the y-axis is different for 
each organ.  
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Figure 3. (A) CLRs mRNA expression in mouse kidney upon induction of IRI; (B) CLRs 
mRNA expression in mouse kidney upon induction of UUO; (C) CLRs mRNA expression 
in mouse kidney upon induction of lupus nephritis (LN). Real-time PCR was performed on 
cDNAs derived from murine kidney tissue from five to ten C57BL/6 mice that underwent 
ischemia reperfusion injury (IRI) (A), unilateral ureteral obstruction (UUO) (B) or 
progressive systemic autoimmunity with lupus nephritis in MRLlpr mice (C) as described 
in methods. Biological replicates were quantified and normalized to 18s rRNA level. The 
results in the table are expressed relative to the respective expression level of each 
transcript in sham operated kidney (A, B) or six week old MRLlpr mice (C). In the table, 
red shades indicate higher and green shades indicate lower mRNA levels as compared to 
the respective mRNA levels in spleen. Basal mRNA levels in control kidney are illustrated 
in the histogram below the table. Data in histograms represents means ± SEM. * In the 
tables indicates statistical significance p < 0.05. 
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Figure 4. Renal leukocyte recruitment upon renal ischemia-reperfusion injury. Kidneys 
were obtained from all IRI mice at various time intervals as indicated. Immunostaining for 
macrophages and T-cells was performed on renal sections as described in material and 
methods. Data represents positive stained surface in percent and are shown as mean ± SEM 
from 8 to 12 mice (at least 25 hpf) of each group. F4/80, DAP-12 and Syk 
immunostainings were performed on paraffin embedded renal sections, obtained from mice 
10 days after IRI, as described in material and methods. Data shows most representative 
results from each group. Data in histograms represents means ± SEM. ** Indicates 
statistical significance p < 0.01, *** indicates statistical significance p < 0.005. 
 
2.4. C-Type Lectin Receptor mRNA Expression in Progressive Renal Fibrosis 
Progressive tissue fibrosis is a common consequence of persistent sterile tissue inflammation [13]. 
We used unilateral ureteral ligation as a sterile model of progressive renal fibrosis. As unilateral 
ureteral obstruction (UUO) induced the intrarenal expression of not only proinflammatory but also 
profibrotic mediators, we compared renal mRNA expression level of CLRs and their adaptor 
molecules in obstructed kidney in relation to sham operated kidney at 2, 6 and 10 days after  
surgery (Figure 3B). Groups of C57BL/6 mice underwent surgery as described in material and 
methods. Most CLR were induced upon ureteral ligation especially Dectin-1, MR1, MR2, DC-SIGN, 
Syk, Card-9, Tim-3, Trem-1, and DAP-12. Immunostaining of paraffin-embedded tissue revealed 
increased numbers of CD3+ and F4/80+ immune cells in the renal interstitial compartment 2, 6, and  
10 days after unilateral ureteral ligation. We performed co-immunostaining of Syk and DAP-12 with 
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the macrophage marker F4/80. Co-expression of F4/80 marker with Syk or DAP-12 revealed that 
expression of CLRs correlates with the infiltration of F4/80 positive macrophages (Figure 5). Thus, the 
massive infiltration of macrophages and T cells into the interstitial compartment of the obstructed 
kidney is associated with a strong induction of multiple CLRs. 
Figure 5. Renal leukocyte recruitment upon unilateral ureteral obstruction. Kidneys were 
obtained from mice after UUO at various time intervals as indicated. Immunostaining for 
macrophages and T-cells was performed on renal sections as described in material and 
methods. Data represents positive stained surface in percent and are shown as mean ± SEM 
from 8 to 12 mice (at least 25 hpf) of each group. F4/80, DAP-12 and Syk 
immunostainings were performed on paraffin embedded renal sections, obtained from  
mice 10 days after UUO, as described in material and methods. Data shows most 
representative results from each group. Data in histograms represents means ± SEM.  
** Indicates statistical significance p < 0.01, *** indicates statistical significance p < 0.005. 
 
2.5. C-Type Lectin Receptor mRNA Expression in Systemic Autoimmunity and Immune  
Complex Glomerulonephritis 
Autoimmune diseases are a consequence of immunity directed to the organism itself. We used a 
severe model of systemic lupus erythematosus to study expression of CLRs in kidney pathology. 
MRLlpr mice develop multiple auto-antibodies which results in deposition of immune complexes in 
kidney and renal inflammation. We analysed basal CLRs mRNA expression levels in kidney of 
MRLlpr mice at days 42, 70, 98 and 126 [14] (Figure 3C). The basal mRNA expression profiles of 
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tested CLRs in young MRLlpr mice, which had not yet developed the autoimmune syndrome, were 
comparable to these found in C57BL/6 mice. Surprisingly, mRNA expression levels in kidneys from 
MRLlpr mice decreased with time in the immune complex glomerulonephritis model of autoimmune 
disease, even though an increased infiltration of macrophages and T-cells was observed. Only  
Dectin-1, Syk, Card-9 and DAP-12 mRNA expression increased in the final phase of the disease at 126 
days. However, co-staining of Syk and DAP-12 with F4/80 showed only weak expression of these 
proteins within renal macrophages (Figure 6). Together, immune complex glomerulonephritis is 
associated with decreased expression of multiple CLRs, except Dectin-1, Syk, Card-9 and DAP-12, 
which are up-regulated in the last stages of the disease. 
Figure 6. Renal leukocyte recruitment during systemic lupus of MRLpr mice. Kidneys 
were obtained from MRLlpr mice at various time intervals as indicated. Immunostaining 
for macrophages and T-cells was performed on renal sections as described in material and 
methods. Data represents positive stained surface in percent and are shown as mean ± SEM 
from 8 to 12 mice (at least 25 hpf) of each group. F4/80, DAP-12 and Syk 
immunostainings were performed on paraffin embedded renal sections as described in 
material and methods. Kidneys were obtained from 126 days old MRLlpr mice. Glomeruli 
are indicated by encircling them. Data shows most representative results from each group. 
Data in histograms represents means ± SEM. * Indicates statistical significance p < 0.05. 
 
2.6. Role of C-Type Lectin Receptors in Tissue Homeostasis  
Pattern recognition molecules play an important role in tissue homeostasis [15] and responses to 
stress signals, such as infections or tissue injury [16,17]. Some C-type lectine receptors, together with 
other receptors such as TLRs, nucleotide-oligomerization domain (Nod)-like receptors (NLRs) and 
retinoic acid-inducible gene-1 (RIG-1)-like receptors (RLRs), play a central role in innate immunity by 
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mediating recognition of PAMPs and DAMPs. CLRs also affect antigen presentation, expression of 
adhesion molecules and tissue regeneration [2]. Most of the PRRs are expressed by professional 
antigen presenting cells such as macrophages and dendritic cells. These cells contain a set of receptors 
that recognise, capture, and internalise antigens [18]. Most CLRs function as antigen receptors that are 
particularly involved in self-antigen capture and presentation. By recruiting other signaling molecules 
CLRs are able not only to signal independently, but also to modulate the signaling cascade coming 
from other PRRs such as TLRs [18]. So far little is known about the respective expression profiles of 
the CLRs. Therefore, we determined their organ-specific expression and their adaptor molecules in 
humans and mice. We also studied the expression of single molecules in particular kidney disease 
models such as unilateral ureteral obstruction (UUO), ischemia reperfusion injury (IRI), and lupus 
nephritis (LN) both on mRNA and protein level. Previously Zarember, et al. described the mRNA 
expression of all known human TLRs, RP105, and several other molecules important in TLR function 
in human organs and peripheral blood leukocytes [11]. The study showed that most of the tissues 
express at least one TLR and spleen and PBLs express almost all TLRs. Moreover some of the TLRs 
appeared to be more restricted to B cells, suggesting the role of TLRs in adaptive immunity [11]. Our 
previous study found mRNA levels of most cytosolic pattern recognition molecules in human heart, 
small intestine, colon, and kidney to be lower as compared to mRNA levels in spleens [19]. This might 
relate to the number of immune cells in these organs. Furthermore, we observed some species-specific 
differences in their expression upon stimulation. Murine monocytes strongly up-regulated cytosolic 
pattern recognition molecules upon stimulation, whereas human monocytes down-regulated receptor 
expression upon stimulation [19]. Consistent with this observation and using human organ cDNA from 
the same tissues we found the mRNA levels of most tested CLRs and their signaling molecules in 
human small intestine, colon, and kidney to be lower as compared to spleen. However, lung expressed 
higher levels of selected molecules, except for Dec-205 as compared to spleen. High expression of 
Dec-205 correlates with the increased amount of lymphoid-related regulatory type of DC [20]. 
Expression of this receptor was only slightly detectable in human spleen, thymus, lung, liver and 
kidney. Mouse tissue samples showed similar expression patterns, however small intestine appeared to 
be an organ with a higher expression of Dec-205. Disease models did not affect the expression of  
Dec-205. The Syk-coupled C-type lectin receptor Dectin-1 was identified as an important receptor for 
the innate recognition and response to fungal pathogens [21]. Dectin-1 deficiency correlates with 
hypersusceptibility to mucocutaneous fungal infection in humans [21]. Consistent with its role as a 
pattern recognition receptor, Dectin-1 mRNA levels should be increased in tissues with an external 
interface. This was true for the lung; however, we did not observe significant expression in the 
gastrointestinal tract. After activation of Dectin-1, the Syk–dependent signaling cascade leads to an 
assembly of the Card-9/Bcl-10/Malt-1 complex. This process is not only activated by phosphorylation 
and ubiquitination, but is also influenced by Card-9 expression. Increased expression of the signaling 
mediator Card-9, i.e., in many infections and proinflammatory conditions, might help to amplify the 
signal coming from surface receptors. However, activation of some receptors (for example PPAR-γ) 
was shown to inhibit Dectin-1–induced activation of NF-κB and MAPK signaling cascades by 
suppressing Card-9 [22]. Our study showed decreased or unchanged expression of all three compounds 
of the Syk-dependent signaling complex Card-9/Bcl-10/Malt-1 upon ischemia reperfusion injury but 
not upon UUO, where expression of all three mRNAs increased. Syk is a non-receptor protein tyrosine 
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kinase that transduces signals that are involved in the control of a variety of cellular processes such as 
proliferation, differentiation, angiogenesis, and adhesion [23–25]. The constitutive expression levels of 
Syk were low in most human and mouse organs. However, the expression of Syk increased  
up to 27 times upon UUO as well as during renal ischemia reperfusion injury and lupus nephritis. This 
might be due to increased leukocyte adhesion and vascular development in injured tissue. Src signaling 
is also downstream of Dectin-1 activation [26]. We did not observe striking differences in expression 
of Src, because this molecule is probably normally maintained in an inactive state, but can be activated 
during mitosis [26]. High relative expression in brain and small intestine in mice results from barely 
detectable Src expression in spleen as the reference organ. Mouse kidney expressed high levels of 
MR2 which is involved in the processes of renal fibrosis [27]. MR2-deficient mice display aggravated 
renal fibrosis more than wild type controls which most likely results from a deregulated lysosomal 
collagen turnover [27]. Consistent with these data, our studies showed that MR2 expression was  
up-regulated upon UUO-induced renal fibrosis but not in IRI which is rather an acute tubular injury 
model devoid of fibrosis.  
We also observed strong expression of Galectin-1 in most of the organs in humans but only in 
spleen, thymus, small intestine, kidney and muscle in mice. This wide expression pattern may be due 
to the fact that Galectin-1 can be found intracellularly, extracellularly and at the cell surface; and its 
varying functions depends on its location. For example, intracellular Galectin-1 is involved in the  
cell-cycle, RNA splicing, and transcriptional regulation; whereas extracellular and cell-surface-bound 
forms are involved in cell–cell interactions, immune response and apoptosis [28,29]. Surprisingly, 
Galectin-1 seems to be only slightly regulated during UUO, IRI or LN development. DAP-12 signaling 
is relevant in mature differentiated mononuclear phagocytes [30]. DAP-12 mRNA was strongly 
upregulated in kidneys upon UUO and in late stage lupus nephritis. Unfortunately, 
immunohistochemical studies that validate mRNA expression at the protein level and inform about the 
cellular distribution of CLRs in human tissues are mostly lacking. We observed expression levels of 
selected proteins upon UUO and IRI and co-localised expression within the F4/80+ macrophages as 
well as CD3+ cells indicating that the expressions of Syk and DAP-12 are restricted to intrarenal 
mononuclear phagocytes which are known to contribute in different ways to inflammation and repair 
of injured organs [31]. To better understand their functional contributions to the disease process 
interventional studies with mutant mice or suitable antagonists need to be performed applying  
organ-specific disease models.  
3. Experimental Section  
3.1. Animal Studies 
Six to eight week old C57BL/6 mice were obtained from Charles River, Sulzfeld, Germany, and 
housed in groups of five mice with a 12 h dark/light cycle and unlimited access to food and water. 
Mice were sacrificed by cervical dislocation [32]. Solid organs samples were kept in RNAlater reagent 
and total RNA was prepared, quality checked, and reverse transcribed into cDNA (described in 3.3.). 
For PCR, independent pools of five samples each were used. Ischemia reperfusion injury (IRI): groups 
of six to eight week old C57BL/6 mice (n = 5–10) underwent unilateral renal pedicle clamping for  
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45 min as a model of ischemia-reperfusion as previously described [33]. Body temperature was 
maintained at 37 °C throughout the procedure by placing the mice on a heating pad. Mice were 
sacrificed 1, 5, and 10 days after the procedure; injured and contralateral kidneys were harvested for 
RNA isolation and immunohistostaining. Unilateral ureteral obstruction (UUO): groups of six to eight 
week old C57BL/6 mice underwent unilateral ureteral obstruction as a model of progressive renal 
fibrosis as previously described [34] and were sacrificed 2, 6, and 10 days after surgery. Contralateral 
kidneys served as intra-individual control. Autoimmune disorder: groups of female MRL or MRL/lpr 
mice with spontaneous lupus-like autoimmunity were housed under sterile conditions and sacrificed at 
age of 6, 10, 14, and 18 weeks as described [35]. All experimental procedures were performed 
according to the German animal care and ethics legislation and had been approved by the local 
government authorities. 
3.2. Human Solid Organ cDNA 
Human solid organ pre-normalized cDNAs derived from poly-(A)-selected DNase-treated RNAs 
were purified from pools of healthy human tissues as obtained from Clontech, Mountain View, CA.  
As only a single pool was available for each organ no studies on biological replicates allowing 
statistics could be performed. According to Clontech, all human samples were purchased and imported 
in accordance with all local laws and regulations.  
3.3. Quantitative Real-Time RT-PCR  
Human solid organ prenormalized cDNAs derived from poly-(A)-selected DNase-treated RNAs 
purified from pools of healthy human tissues were obtained from Clontech, Mountain View, CA, USA. 
An equal amount of cDNA from each individual preparation was used as a template in PCR with 
primers for each of the fours tested reference genes (α-tubulin, β-actin, GAPDH/G3PDH, 
phospholipase A2) (Table 1). An 18s ribosomal unit was not detectable in poly-(A)-purified RNAs. 
The PCR product band was determined by video imaging and computer analysis, and band intensity 
was determined. If necessary, the concentration of individual cDNA preparations was than adjusted so 
that the average band intensity for the reference genes used to normalize the panel varied no more than 
20%. As only a single pool was available for each organ no studies on biological replicates allowing 
statistics could be performed. According to Clontech all human samples were purchased and imported 
in accordance with all local laws and regulations. Donors were tested to be negative for HIV, hepatitis 
B virus, and hepatitis C virus. Further exclusion criteria were as follows, manifest infections during the 
last 4 weeks, fever, symptomatic allergies, abnormal blood cell counts, increased liver enzymes, or 
medication of any kind except vitamins and oral contraceptives. High quality, DNA-free RNA was 
isolated from freshly harvested tissues. Tissues were kept in RNAlater reagent and RNA was isolated 
from same tissue mass (10 mg) with Pure Link RNA Mini Kit according to manufacture instructions 
(sample size normalization). Samples were digested with DNAse solution and additional washing steps 
were performed to remove traces of DNAse. Concentrations of aqueous RNA samples were measured 
with NanoDrop 1000 Spectrophotometer. Only samples with absorbance 260/280 between 1.95–2.05 
were considered as pure RNA, the integrity of the total RNA was determined by electrophoresis on 2% 
(w/v) agarose gels. 1 µg of good quality RNA was preceded to cDNA (second normalization step). 
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Thermo stable RNAse inhibitor was used during reverse transcription. Reverse transcription was 
performed with same reaction mix containing Superscript II reverse transcriptase (Invitrogene), 
dNTPs, hexanucleotides, linear acrylamid, DTT and 5× Superscript buffers using standard protocol. 
Same amount of RNA (1 µg) was heated to 65 °C for 5 min put on ice. RT-PCR reaction was 
performed for 90 min at 42 °C. Mouse cDNAs from organs and disease models were additionally 
normalized with α-tubulin, β-actin, GAPDH/G3PDH, phospholipase A2, β-2-microglobulin and 
ribosomal unit 18 s (Table 2). GAPDH was chosen for analysis of the tissues and ribosomal protein 18 
s was used as a reference gene for disease models (little variation between disease models, Table 3). 
Above mentioned reference genes were tested in 11 (organs) or 20 (IRI, UUO or LN) samples. 
Geometric mean (GM), arithmetic mean (AM) minimal value, maximal value, standard deviation 
(SD), variance and coefficient of variance (CV) were calculated. GAPDH and 18 s were chosen as the 
most stably expressed in organs and disease models respectively. CLR mRNAs expression in human 
and mouse solid organs cDNA was quantified by real-time RT-PCR using GAPDH as housekeeper 
genes. Each PCR reaction (20 µL) contained 10× Taq Polymerase Buffer, Taq Polymerase, dNTPs, 
BSA, PCR Optimizer, SYBR green solution, MgCl2, gene specific primers and 0.2 µL of synthesized 
cDNA. SYBR Green Dye detection system (SYBR Green I 96 protocol LC480 Roche running 
program) was used for amplification. Quantitative real-time PCR was performed on Light Cycler 480 
(Roche, Mannheim, Germany). Each amplification step included initiation phase 95 °C, annealing 
phase 60 °C and amplification phase 72 °C and was repeated 45 times. Gene-specific primers (300 nM, 
Metabion, Martinsried, Germany) were used as listed in Table 4. Controls consisting of ddH2O were 
negative for target and housekeeper genes. Primers were designed to be cDNA specific and to target 
possibly all known transcripts of genes of interest. In silico specificity screen (BLAST) was 
performed. The lengths of amplicons were between 80 and 130 bp. The kinetics of the PCR 
amplification (efficiency) was calculated for every set of primers. The efficiency-corrected 
quantification was performed automatically by the LightCycler 480 based on extern standard curves 
describing the PCR efficiencies of the target and the reference gene [ratio = EtargetΔCPtarget (control − 
sample)/ErefΔCPref (control − sample)]. To reduce the risk of false positive Cp the high confidence algorithm was 
used. All the samples that during the amplification reaction did not rise above the background 
fluorescence (crossing point Cp or quantification cycle Cq) of 40 cycles were described as not detected 
(n.d. = not detected in the figures). Crossing points between 5 and 40 cycles were considered as 
detectable. The melting curves profiles were analyzed for every sample to detect unspecific products 
and primer dimers. Products were visualized on agarose gels, extracted and analyzed for sequence.  
Table 1. Descriptive statistics of candidate human reference genes (RG) based on their 
crossing point (CP) values. Abbreviations: N: number of samples; GM: the geometric mean 
of CP; AM: the arithmetic mean of CP; Min CP and Max CP: the extreme values of CP; 
SD: the standard deviation of the CP; CV: the coefficient of variance expressed as a 
percentage on the CP level.  
 GAPDH Actin α-tubulin Phospholipase A2 β-mikroglobulin 
N 11 11 11 11 11 
GM 20.35 17.97 18.98 20.55 16.49 
AM 20.36 18.01 19.01 20.60 16.58 
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Table 1. Cont. 
 GAPDH Actin α-tubulin Phospholipase A2 β-mikroglobulin 
Minimum 19.12 17.35 17.96 18.39 13.71 
Maximum 21.59 20.34 20.40 23.88 21.13 
SD 0.75 1.17 1.12 1.49 1.84 
Variance 0.56 1.36 1.26 2.21 3.38 
CV 0.11 0.24 0.24 0.45 0.56 
Table 2. Descriptive statistics of candidate mouse reference genes (RG) based on their 
crossing point (CP) values. Abbreviations: N: number of samples; GM: the geometric 
mean of CP; AM: the arithmetic mean of CP; Min CP and Max CP: the extreme values of 
CP; SD: the standard deviation of the CP; CV: the coefficient of variance expressed as a 
percentage on the CP level.  
 GAPDH Actin α-tubulin Phospholipase A2 β-mikroglobulin 18 s 
N 11 11 11 11 11 11 
GM 20.33 18.46 20.27 20.83 18.24 8.32 
AM 20.34 18.49 20.29 20.88 18.37 8.40 
Minimum 19.31 16.85 18.98 18.75 15.28 7.33 
Maximum 21.38 20.01 21.28 23.84 21.07 11.22 
SD 0.61 1.03 0.75 1.58 2.25 1.24 
Variance 0.38 1.07 0.56 2.50 5.08 1.53 
CV 0.08 0.20 0.11 0.52 0.93 0.13 
Table 3. Descriptive statistics of 18s ribosomal unit reference gene based on its crossing 
point (CP) values. Abbreviations: N: number of samples; GM: the geometric mean of CP; 
AM: the arithmetic mean of CP; Min CP and Max CP: the extreme values of CP; SD: the 
standard deviation of the CP; CV: the coefficient of variance expressed as a percentage on 
the CP level.  
 Spleen MRL Kidney MRL UUO IRI 
N 41 55 25 25 
GM 9.38 7.86 9.22 9.02 
AM 9.40 7.91 9.23 9.03 
Minimum 8.10 6.44 8.36 7.95 
Maximum 10.90 9.82 10.41 9.89 
SD 0.70 0.88 0.52 0.56 
Variance 0.48 0.77 0.27 0.31 
CV 0.05 0.06 0.03 0.03 
Table 4. Gene-specific primers with example efficiencies (shown for the pooled various 
organs cDNA samples) and accessions numbers. 
 Mouse right primer sequence Mouse left primer sequence Accession Nr. Efficiency Error value 
Dectin-1 GTGCAGTAAGCTTTCCTGGG TCCCGCAATCAGAGTGAAG NM_020008 1.99 0.0007 
MR1 GTGGATTGTCTTGTGGAGCA TTGTGGTGAGCTGAAAGGTG NM_008625 2.16 0.0140 
MR2 CTCCAGACAGCCCTGCAT GTCTTGCTTCTCGGGGGACT NM_008626 1.81 0.0156 
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Table 4. Cont. 
 Mouse right primer sequence Mouse left primer sequence Accession Nr. Efficiency Error value 
DC-SIGN CTGCACAGTCTTCCTCTCCC  TGGTACTGGGTAGATGGTTCA NM_133238 2.00 0.0188 
Syk TCTGCACCCCTTCAGAGTTC TCCTTTCAACGTTCCATGCT NM_011518 1.79 0.0510 
Card-9 ATGAGGCTGTGCCTGAGC GCTGCAAGGACGAGAACTATG NM_001037747 2.08 0.0174 
Bcl-10 TGCACGTAGATGATCAAAATGTC ACGGAGGAGGATTTGACTGA NM_009740 2.13 0.0740 
Malt-1 CAAAAGGATGTCCAGTTGCC CACACTGAGGTTCTTCCGCT NM_172833 1.82 0.0065 
Src TACCACTCCTCAGCCTGGAT ACACGAGGAAGGTGGATGTC NM_009271 2.19 0.0374 
Dec-205 TTCAGACCAATCCACAACCA AGCTCACCTACCCAGCTTCA NM_013825 2.03 0.1900 
Galectin-1 GCGAGGATTGAAGTGTAGGC AATGTCTCAAAGTTCGGGGA NM_008495 1.96 0.0085 
Tim-3  AGCCCATGTGGAAATTTTTG CTCCAAGAACCCTAACCACG NM_134250 2.00 0.0145 
Trem-1 CACTGTCAAAGTCTGGCCCT ACTGCTGTGCGTGTTCTTTG NM_021406 2.00 0.0740 
DAP-12 TTGCCTCTGTGTGTTGAGGT CGGAAACAACACATTGCTGA NM_011662 1.90 0.0379 
 Human right primer sequence Human left primer sequence Accession Nr Efficiency Error value 
Dectin-1 GGAGATGGGTTTTCTTGGGT  GACTGAGGTACCATGGCTCTG NM_022570 2.06 0.0541 
MR1 CCCATCGGAATTTCTGTGAT  GGGTGCTGTTCTCCTACTGG NM_002438 2.06 0.0587 
MR2 CAGTCCATGGCTGAAGATGA GCTGCGTCCTGCTCCTC NM_006039 2.22 0.1030 
DC-SIGN TTGTTGGGCTCTCCTCTGTT AAGTAACCGCTTCACCTGGA NM_021155 2.00 0.0122 
Syk AAAGAAGGGCAGGTGGTTG GAGAGCGAGGAGGAGCG  NM_003177 2.07 0.0197 
Card-9 CTGTGCGTGCAGCTCCT TCCAAGATGTACAAGGACCG NM_052813 2.10 0.2160 
Bcl-10 TTGCACGTAGATGATCAAAATGT TCCCTCACCGAGGAGGAC NM_003921 2.00 0.0178 
Malt-1 GCCAAGACTGCCTTTGACTC TTTCCTGCAGGCTATGGAAC NM_006785 2.17 0.0364 
Src TAGTTGCTGGGGATGTAGCC CTGTCCTTCAAGAAAGGCGA  NM_005417 2.12 0.0134 
Dec-205  CCAGCCAAAAACTTCTCATTT  TGGCTTCATGGGTCATGTTA  NM_002349 2.01 0.2010 
Galectin-1 AGGTTGTTGCTGTCTTTGCC  CAAACCTGGAGAGTGCCTTC  NM_002305 1.87 0.0810 
Tim-3  GCGAATTCCCTCTGCTACTG  CTTCGGCGCTTTAATTTTCA NM_032782 2.02 0.0914 
Trem-1 TACTCAGGAATCCACCAGCC CCGATGTCTCCACTCCTGAC NM_018643 1.92 0.0731 
DAP-12 GTCATGATTCGGGCTCATTT  GAGACCGAGTCGCCTTATCA  NM_003332 2.08 0.0191 
3.4. Morphological Evaluation 
Tissue sections from the kidneys of each mouse were fixed in 10% formalin in PBS and embedded 
in paraffin. Two micromolar per liter sections were stained with rat anti-F4/80 (Serotec, Oxford, UK, 
1:50) and CD3 primary antibody. To count interstitial cells at least 25 high power fields (hpf, 100×) 
per group were analyzed. Positive areas were digitally quantified per high power field with use of 
Photoshop software. Data represents means ± SEM. For detection of CLRs in intrarenal macrophages 
immunohistochemistry was used. Rat anti-mouse F4/80 antibodies (Serotec, 1:50) were used for 
staining intrarenal macrophages. Rabbit polyclonal anti-Syk (Abcam, Cambridge, UK, 1:100 dilution) 
and rabbit polyclonal antibody raised against amino acids 1-113 of DAP-12 (Santa Cruz 
Biotechnology, Heidelberg, Germany, 1:100 dilution) were used. Appropriate secondary anti-rat and 
anti-rabbit FITC- or PE-coupled were used for visualizing the signal.  
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3.5. Statistical Analysis 
Data were expressed as mean ± standard error of the mean (SEM). Comparisons between groups 
were performed using univariate ANOVA (posthoc Bonferroni’s correction was used for multiple 
comparisons). A value of p < 0.05 indicated statistical significance.  
4. Conclusions 
Together, we identified significant differences in the mRNA expression of CLRs and adaptor 
molecules in human and mouse solid organs and defined their cell type-specific expression in different 
inflammatory conditions. These findings can help to generate novel hypotheses on the role of 
described molecules in selected organ pathologies. Furthermore, this study shows that species-specific 
expression of single molecules needs to be considered in the interpretation of human studies and 
studies performed in rodents.  
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